J. C. Chabala

发表

Avermectins. Structure determination

A. W. Douglas, Jack L. Smith, M. Fisher, 1981 .

Synthesis of pochoxime prodrugs as potent HSP90 inhibitors.

A. Rubenstein, J. Heck, S. Barluenga, 2009, Bioorganic & medicinal chemistry letters.

22, 23--dihydroavermectin B1, a new broad-spectrum antiparasitic agent.

L. S. Blair, W. Campbell, J. Egerton, 1980, The British veterinary journal.

Composes pour l'inhibition enzymatique

Barry A. Bunin, R. Borchardt, C. Crews, 2005 .

Ivermectin, a new broad-spectrum antiparasitic agent.

W. Campbell, J. Egerton, M. Fisher, 1980, Journal of medicinal chemistry.

Antitumor activity of a kinesin inhibitor.

K. Wood, J. Finer, J. Mak, 2004, Cancer research.

MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.

D. Szalkowski, D. Macintyre, A. Alberts, 1993, Journal of lipid mediators.

Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys.

B. Arison, J. C. Chabala, M. Ponpipom, 1991, Xenobiotica; the fate of foreign compounds in biological systems.

Synthesis and biological activity of MK 287(L-680, 573) a potent specific and orally active PAF receptor antagonist.

Margaret S. Wu, T. Doebber, D. Macintyre, 1991 .

(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.

T. Doebber, A. Alberts, J. C. Chabala, 1988, Biochemical and biophysical research communications.

Synthesis and biological activity of the platelet-activating factor antagonist (±)-trans-2-(3-methoxy-4-phenylsulfonylethoxy-5-n-propylsulfonylphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-671,284) and its analogs

Margaret S. Wu, T. Doebber, A. Alberts, 1992 .

The preparation of 3-cholesteryl 6-(thioglycosyl)hexyl ethers and their incorporation into liposomes

J. C. Chabala, T. Shen, 1978 .

Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.

A. Alberts, J. C. Chabala, S. Hwang, 1988, The Journal of pharmacology and experimental therapeutics.

Benzylated 1,2,3-triazoles as anticoccidiostats.

J. C. Chabala, E. Harris, T. Beattie, 1991, Journal of medicinal chemistry.

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.

T. Bach, A. Alberts, J. C. Chabala, 1992, Journal of medicinal chemistry.

Chapter 16. Veterinary Drugs

M. Fisher, J. C. Chabala, H. Mrozik, 1981 .

AVERMECTINS. STRUCTURE DETERMINATION

A. W. Douglas, Jack L. Smith, M. Fisher, 1981 .

Synthesis of 1,5-diazacyclooctanes from 2,4,6,8-tetraketo-1,5-diazabicyclo[3,3,0]octanes

D. Kemp, J. C. Chabala, S. Marson, 1978 .

The chemistry of 2,2-dichloro-3-p-nitrophenyl-1-phenyl aziridine, 6. Preparation of a stable aziridinyl C- anion, 3.

J. C. Chabala, V. Pascucci, G. R. Stevenson, 1972 .

Total synthesis of L-659,699, a novel inhibitor of cholesterol biosynthesis

J. Heck, J. C. Chabala, S. Yang, 1989 .

Chemistry of Antiprotozoal Agents

J. C. Chabala, M. W. Miller, Max W. Miller, 1986 .

N‐Alkylindoles from the Alkylation of Sodium Indolide in Hexamethylphosphoric Triamide: 1‐Benzylindole

J. C. Chabala, G. M. Rubottom, 2003 .

Synthesis of milbemycins from avermectins

M. Fisher, J. C. Chabala, P. Eskola, 1983 .

THE PREPARATION OF α,β-ACETYLENIC KETONES BY CONDENSATION OF LITHIUM ACETYLIDES WITH LACTONES

J. C. Chabala, J. E. Vincent, 1978 .

IVERMECTIN, A NEW BROAD-SPECTRUM ANTIPARASITIC AGENT

W. Campbell, J. Egerton, M. Fisher, 1981 .

1-(Substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors ofTrypanosoma cruzi in mice

A. Patchett, M. Fisher, M. Wyvratt, 1991, Experientia.

The inhibition of cytoplasmic acetoacetyl-CoA thiolase by a triyne carbonate (L-660, 631).

A. Alberts, J. Chen, J. C. Chabala, 1989, Biochemical and biophysical research communications.

Binary encoded small-molecule libraries in drug discovery and optimization

N. Sigal, J. Reader, J. Baldwin, 1995 .

Solid-phase combinatorial chemistry and novel tagging methods for identifying leads.

J. C. Chabala, 1995, Current opinion in biotechnology.

The preparation and reactions of 2-azidocarbapenems

J. C. Chabala, B. Christensen, M. F. Woods, 1985 .

The Alkylation of Indole Sodium Salt

J. C. Chabala, G. M. Rubottom, 2002 .

Inhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659,699.

A. Alberts, J. Chen, J. C. Chabala, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Potent inhibitory effect of antibiotic 1233A on cholesterol biosynthesis which specifically blocks 3-hydroxy-3-methylglutaryl coenzyme A synthase.

S. Ōmura, A. Patchett, A. Alberts, 1987, The Journal of antibiotics.